The story of Viagra presents a nuanced case for stakeholders in the medicinal sector. While initially a blockbuster success, creating huge profits, the intellectual property end and the subsequent entry of off-brand https://knockoff361676.collectblogs.com/86424101/sildenafil-and-big-pharma-a-hazardous-play